Physician profile
Sanjay Patel
NPI 1669418331
$2,377.08
in general payments reported to CMS, 2019-2025
22 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $67.44 · 2021: $229 · 2022: $222 · 2023: $403 · 2024: $671 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451 · Consulting Fee: $19.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.48 |
| Consulting Fee | $19.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $982.80 | 2023-2025 | |
| Organogenesis INC. | $219.14 | 2019 | |
| Biocryst US Sales Co., LLC | $214.13 | 2023-2025 | Orladeyo |
| Regeneron Healthcare Solutions, INC. | $162.71 | 2019-2022 | |
| Electromed, INC. | $111.88 | 2021-2022 | |
| Grifols USA, LLC | $111.66 | 2021-2025 | Xembify |
| Astrazeneca Pharmaceuticals Lp | $89.79 | 2020-2022 | |
| Alk-Abello, INC | $75.00 | 2021 | |
| Genzyme Corporation | $69.97 | 2021-2025 | |
| Integra Lifesciences Corporation | $46.57 | 2019-2020 | |
| Ovik Health, LLC | $39.00 | 2019-2021 | |
| Solventum Corporation | $38.14 | 2025 | Activ.A.C. |
| Smith+Nephew, INC. | $37.79 | 2020-2023 | Grafix Pl |
| Janssen Pharmaceuticals, INC | $35.56 | 2024 | Invega Sustenna, Invega Trinza |
| Harmony Biosciences LLC | $24.24 | 2023 | Wakix |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Oxygen Therapy INC. | $20.16 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Adma Biomanufacturing LLC | $19.92 | 2024-2025 | |
| Covis Pharma Gmbh | $18.13 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.04 | 2021 | |
| Glaxosmithkline, LLC. | $15.46 | 2024 | Trelegy Ellipta, Arexvy |
| Inogen, INC. | $14.89 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Inspire Medical Systems, INC. | $14.10 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.